ISCIII

Inicio de sesión
Selecionar página

Publicaciones

Publicaciones de los últimos 7 años:


  • Higueras MA, Jimenez-Garcia L, Herranz S, Hortelano S, Luque A. Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response. Journal of visualized experiments : JoVE. 2017(127). (A) IF: 1.232
  • Olivar R, Luque A, Cardenas-Brito S, Naranjo-Gomez M, Blom AM, Borras FE, et al. The Complement Inhibitor Factor H Generates an Anti-Inflammatory and Tolerogenic State in Monocyte-Derived Dendritic Cells. J Immunol. 2016;196(10):4274-90. (A) IF: 4.856 Q1
  • Jimenez-Garcia L, Traves PG, Lopez-Fontal R, Herranz S, Higueras MA, de Las Heras B, et al. 8,9-Dehydrohispanolone-15,16-lactol diterpene prevents LPS-triggered inflammatory responses by inhibiting endothelial activation. Biochem J. 2016;473(14):2061-71. (A) IF: 3.797
  • Jimenez-Garcia L, Herranz S, Higueras MA, Luque A, Hortelano S. Tumor suppressor ARF regulates tissue microenvironment and tumor growth through modulation of macrophage polarization. Oncotarget. 2016. (A) IF: 5.168 Q1
  • Garcia-Quintans N, Prieto I, Sanchez-Ramos C, Luque A, Arza E, Olmos Y, et al. Regulation of endothelial dynamics by PGC-1alpha relies on ROS control of VEGF-A signaling. Free Radical Bio Med. 2016;93:41-51. (A) IF:5.606 Q1
  • Franco ML, Melero C, Sarasola E, Acebo P, Luque A, Calatayud-Baselga I, et al. Mutations in TrkA Causing Congenital Insensitivity to Pain with Anhidrosis (CIPA) Induce Misfolding, Aggregation, and Mutation-dependent Neurodegeneration by Dysfunction of the Autophagic Flux. J. Biol Chem. 2016;291(41):21363-74. (A) IF: 4.125
  • Abos B, Wang T, Castro R, Granja AG, Leal E, Havixbeck J, et al. Distinct Differentiation Programs Triggered by IL-6 and LPS in Teleost IgM(+) B Cells in The Absence of Germinal Centers. Sci Rep. 2016;6:30004. (A) IF: 4.259 Q1
  • Valenzuela-Barra G, Castro C, Figueroa C, Barriga A, Silva X, de Las Heras B, et al. Anti-inflammatory activity and phenolic profile of propolis from two locations in Region Metropolitana de Santiago, Chile. J Ethnopharmacol. 2015;168:37-44. (A) IF: 2.981 Q1
  • Mota A, Jimenez-Garcia L, Herranz S, de Las Heras B, Hortelano S. alpha-Hispanolol sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis via death receptor up-regulation. Toxicol Appl Pharm. 2015;286(3):168-77. (A) IF: 3.847 Q1
  • Jimenez-Garcia L, Herranz S, Luque A, Hortelano S. Critical role of p38 MAPK in IL-4-induced alternative activation of peritoneal macrophages. Eur J Immunol. 2015;45(1):273-86. (A) IF: 4.179
  • Gomez AM, Martinez C, Gonzalez M, Luque A, Melen GJ, Martinez J, et al. Chemokines and relapses in childhood acute lymphoblastic leukemia: A role in migration and in resistance to antileukemic drugs. Blood Cell Mol Dis 2015;55(3):220-7. (A) IF: 2.731
  • Cuadrado-Berrocal I, Guedes G, Estevez-Braun A, Hortelano S, de Las Heras B. Biological evaluation of angular disubstituted naphthoimidazoles as anti-inflammatory agents. Bioorg Med Chem Lett. 2015;25(19):4210-3. (A) IF: 2.486
  • Garcia-Quintans N, Sanchez-Ramos C, Tierrez A, Olmo Y, Luque A, Arza E, et al. Control of endothelial function and angiogenesis by PGC-1alpha relies on ROS control of vascular stability. Free Radical Bio Med.  2014;75 Suppl 1:S5. (A) IF:5.606 Q1
  • Traves PG, Lopez-Fontal R, Cuadrado I, Luque A, Bosca L, de las Heras B, et al. Critical role of the death receptor pathway in the antitumoral effects induced by hispanolone derivatives. Oncogene. 2013;32(2):259-68. (A) IF: 8.559 Q1/D1
  • Oramas-Royo S, Torrejon C, Cuadrado I, Hernandez-Molina R, Hortelano S, Estevez-Braun A, et al. Synthesis and cytotoxic activity of metallic complexes of lawsone. Bioorg Med Chem. 2013;21(9):2471-7. (A) IF:2.331
  • Garaulet G, Alfranca A, Torrente M, Escolano A, Lopez-Fontal R, Hortelano S, et al. IL10 released by a new inflammation-regulated lentiviral system efficiently attenuates zymosan-induced arthritis. Mol Ther. 2013;21(1):119-30. (A) IF: 6.425 Q1/D1
  • Traves PG, Luque A, Hortelano S. Macrophages, inflammation, and tumor suppressors: ARF, a new player in the game. Mediat Inflamm. 2012;2012:568783. (R) IF: 3.882
  • Traves PG, Luque A, Hortelano S. Tumor suppressor ARF: The new player of innate immunity. Oncoimmunology. 2012;1(6):946-7. (R) IF: 7.719 Q1/D1
  • Herranz S, Traves PG, Luque A, Hortelano S. Role of the tumor suppressor ARF in macrophage polarization: Enhancement of the M2 phenotype in ARF-deficient mice. Oncoimmunology. 2012;1(8):1227-38. (A) IF: 7.719 Q1/D1
  • Cuadrado I, Cidre F, Herranz S, Estevez-Braun A, de las Heras B, Hortelano S. Labdanolic acid methyl ester (LAME) exerts anti-inflammatory effects through inhibition of TAK-1 activation. Toxicol Appl Pharmacol. 2012;258(1):109-17. (A) IF: 3.975 Q1
  • Traves PG, Lopez-Fontal R, Luque A, Hortelano S. The tumor suppressor ARF regulates innate immune responses in mice. J Immunol. 2011;187(12):6527-38. (A) IF: 5.788 Q1
  • Hueso-Falcon I, Cuadrado I, Cidre F, Amaro-Luis JM, Ravelo AG, Estevez-Braun A, et al. Synthesis and anti-inflammatory activity of ent-kaurene derivatives. Eur J Med Chem. 2011;46(4):1291-305. (A) IF: 3.346 Q1
  • Lopez-Fontal R, Zeini M, Traves PG, Gomez-Ferreria M, Aranda A, Saez GT, et al. Mice lacking thyroid hormone receptor Beta show enhanced apoptosis and delayed liver commitment for proliferation after partial hepatectomy. PLoS One. 2010;5(1):e8710. (A) IF: 4.411 Q1
  • Hueso-Falcon I, Giron N, Velasco P, Amaro-Luis JM, Ravelo AG, de las Heras B, et al. Synthesis and induction of apoptosis signaling pathway of ent-kaurane derivatives. Bioorg Med Chem. 2010;18(4):1724-35. (A) IF: 2.661
  • Hortelano S, Lopez-Fontal R, Traves PG, Villa N, Grashoff C, Bosca L, et al. ILK mediates LPS-induced vascular adhesion receptor expression and subsequent leucocyte trans-endothelial migration. Cardiovasc Res. 2010; Qº186(2):283-92. (A) IF: 6.051 Q1/D1
  • Giron N, Perez-Sacau E, Lopez-Fontal R, Amaro-Luis JM, Hortelano S, Estevez-Braun A, et al. Evaluation of labdane derivatives as potential anti-inflammatory agents. Eur J Med Chem. 2010;45(7):3155-61. (A) IF: 3.193 Q1